πŸ‡ΊπŸ‡Έ FDA
Patent

US 8334409

Process for purifying rasagiline base

granted A61PA61P25/16A61P43/00

Quick answer

US patent 8334409 (Process for purifying rasagiline base) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/16, A61P43/00